Back

Sacubitril/valsartan in real-life European patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Chronic Heart Failure ePosters Treatment ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Stefano Giovinazzo

IRCCS Policlinic San Martino, Genoa (Italy)

274 More presentations in this session

Presentation thumbnail
Increased myocardial fat supply improves cardiac energetics and function in heart failure
Doctor W. Watson (Cambridge, GB)
Abstract Slides
Presentation thumbnail
Cardiac aging is regulated by autophagic disorder mediated by chronic inflammation via the Rubicon/NOX4 pathway.
Doctor T. Kamihara (Obu, JP)
Abstract Slides
Presentation thumbnail
Participants with diabetes have less augmentation in cardiac function and energetics in response to increased supply of fatty acid
Doctor P. Green (Hobart, AU)
Abstract Slides
Presentation thumbnail
Impaired high-density lipoprotein function in patients with heart failure
Ms L. Emmens (Groningen, NL)
Abstract Slides
Presentation thumbnail
The comparison of clinical significance between atrial and ventricular structural remodeling in patients with heart failure with preserved ejection fraction - insights from PURSUIT-HFpEF registry
Doctor M. Okada (Osaka, JP)
Abstract Slides

Access the full session

Session thumbnail
Chronic Heart Failure ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Which device might help your HFpEF patient?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources